Loading...
Olanzapine: A potent agonist at the hM4D(Gi) DREADD amenable to clinical translation of chemogenetics
Designer receptors exclusively activated by designer drugs (DREADDs) derived from muscarinic receptors not only are a powerful tool to test causality in basic neuroscience but also are potentially amenable to clinical translation. A major obstacle, however, is that the widely used agonist clozapine...
Na minha lista:
| Udgivet i: | Sci Adv |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Association for the Advancement of Science
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469940/ https://ncbi.nlm.nih.gov/pubmed/31001591 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaw1567 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|